Lombard Medical : Grafting For SuccessLombard Medical Home Page



Biotech and medical device stocks are way out of favour at the moment but must be due a bounce some time. Lombard Medical has been massacred by the market yet has had NO product failures to justify that. It is worth a look. To get the thread started, below is a cut and past from the Traders' Room.

Cheers
2Bob

Article today in Shares mag
Shares Mag link

-->All
There has been quite a deluge of information from the company via articles published in The Wall Street Transcript, Shares Magazine, Clinica and Medical Device Technology this past week.

I note that the Medical Device Technology article can now be accessed here:-
Medical Device Technology

and more importantly the Clinica article which is a good balanced view of pospects in my opinion can be accessed here. It may take a minute for the pdf to download:-
Clinica - World Medical Device & Diagnostic News

One can access the TWST transcript summary here:-
The Wall Street Transcript

and the Shares article is reproduced here summarised as may be worth a speculative punt:-
Shares Magazine

Cheers
2Bob

-->All
Investech see a postive share trend.
LOM Chart

-->All
Merrill Lynch have done a short review of AAA stent graft adverse events reported through the FDA in 2002.

ML report that the US market in 2002 was worth 216M with $153M or 71% going to Medtronic's AneuRx and $63M or 29% going to Guidant and their Ancure device. ML estimate that MDT implanted 12,750 devices with a selling price of $12,000 each and GDT implanted 6300 devices at $10,000 each.

Of the total estimated 19,050 devices implanted there were 480 adverse events reported to the FDA of which 58 were deaths. This gives an adverse event rate of 2.5% for all devices implanted and a death rate of 0.3%. The death rate compares favourably with a typical 4% level for surgical repair but that may include more difficult cases. The death rate for both devices is similar. But the GDT device has overall a higher adverse event rate of 3.6% compared to 2.0% for the MDT device.

Clearly there is room for a safer device in the US market.

Cheers
2Bob

There have been positive movements. If you are a Lombard Medical plc holder who did not convert to LMT shares then email me at 2Bob@iname.com and I can provide you with more detail of your holding and its worth.

LOM shareholders (not LMT) now have postal mail calling an EGM on 28th Feb. If your holding is in a nominee account check with your advisor.

Cheers
2Bob :-)